{"schema_version":"secwatch.filing_event.v1","accession":"0001388658-23-000145","form_type":"8-K","ticker":"IRTC","cik":"0001388658","company_name":"iRhythm Holdings, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.829727+00:00","generated_at":"2026-06-08T23:45:06.711689+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"iRhythm Q3 2023 revenue $124.6M (+20% YoY); raises FY2023 guidance to $487.5M-$490M","bullets":["Revenue $124.6M (+20% YoY); net loss $27.1M ($0.89/share) vs $21.5M loss in prior year.","Gross margin 66.2%, down 210 bps due to reserves for excess Zio XT PCBA components.","Record registration volumes; launched next-generation Zio monitor with enhanced features.","FY2023 revenue guidance raised to $487.5M-$490M (~19% YoY growth); adj. EBITDA margin ~0%-0.5%.","Cash and marketable securities $158.5M as of Sept 30, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001388658-23-000145","json":"https://secwatch.observer/filing/0001388658-23-000145.json","markdown":"https://secwatch.observer/filing/0001388658-23-000145.md","text":"https://secwatch.observer/filing/0001388658-23-000145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000145/0001388658-23-000145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000145/irtc-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T23:45:06.711689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3559d1febb218f13c6e2ff59ced1df5dd0022e13","claim":"iRhythm Holdings, Inc. reported for the three and nine months ended September 30, 2023 results: revenue $124.6 million, net income $27.1 million, EPS $0.89 per share. Guidance raised.","evidence_excerpt":"iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three and nine months ended September 30, 2023. Third Quarter 2023 Financial Highlights • Revenue of $124.6 million, a 20.0% increase compared to third quarter 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000145/0001388658-23-000145-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"for the three and nine months ended September 30, 2023"},{"label":"Revenue","value":"$124.6 million"},{"label":"Net income","value":"$27.1 million"},{"label":"EPS","value":"$0.89 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}